Probiodrug AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,879.00
20,920.00
21,368.00
21,904.00
10,298.00
3,783
Total Accounts Receivable
851.00
189.00
125.00
166.00
46.00
91
Other Current Assets
219.00
185.00
233.00
129.00
349.00
108
Total Current Assets
5,949.00
21,294.00
21,726.00
22,199.00
10,693.00
3,982
Net Property, Plant & Equipment
321.00
101.00
81.00
68.00
55.00
56
Total Investments and Advances
3.00
3.00
3.00
3.00
3.00
3
Intangible Assets
101.00
82.00
56.00
96.00
11.00
7
Total Assets
6,374.00
21,480.00
21,866.00
22,366.00
10,762.00
4,048
ST Debt & Current Portion LT Debt
5,346.00
-
-
-
-
Accounts Payable
1,327.00
1,036.00
1,629.00
1,893.00
344.00
Income Tax Payable
2,486.00
2,543.00
2,641.00
2,739.00
-
Other Current Liabilities
174.00
1,001.00
641.00
508.00
324.00
Total Current Liabilities
9,333.00
4,580.00
4,911.00
5,140.00
668.00
Provision for Risks & Charges
1,254.00
929.00
822.00
850.00
1,171.00
Total Liabilities
10,587.00
5,509.00
5,733.00
5,990.00
1,839.00
Common Equity (Total)
4,224.00
15,971.00
16,133.00
16,376.00
8,923.00
Total Shareholders' Equity
4,224.00
15,971.00
16,133.00
16,376.00
8,923.00
Total Equity
4,224.00
15,971.00
16,133.00
16,376.00
8,923.00
Liabilities & Shareholders' Equity
6,374.00
21,480.00
21,866.00
22,366.00
10,762.00
Non-Equity Reserves
11.00
-
-
-
-

About Probiodrug

View Profile
Address
Weinbergweg 22
Halle Sachsen-Anhalt 06120
Germany
Employees -
Website http://www.probiodrug.de
Updated 07/08/2019
Probiodrug AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.